Ultrastructural investigations of Candida albicans after in vitro treatment with the new fungicidal agent rilopirox. 1993

H K Reitze, and D R Dannhorn, and H Hänel, and K A Seitz
Fachbereich Biologie, Philipps-Universität Marburg, Germany.

Candida albicans was maintained in various culture media and incubated with different concentrations of the antifungal agent rilopirox. After fixation, dehydration and embedding in Spurr's medium, the cells were analysed at the ultrastructural level to investigate morphological aspects of the antifungal mode of action of this new hydroxpyridone compound. All untreated or sham-treated control cells exhibited a normal ultrastructural appearance. The cells were surrounded by a multilayered cell wall of typical structure, and the plasmalemma was in close contact with the cell wall. Also, the cell organelles of the protoplast corresponded well with the findings of other authors. After treatment with rilopirox, a variety of ultrastructural changes were seen, and the extent of damage was dependent on the specific culture condition, drug concentration and incubation time. After only 6 h and 1-10 micrograms ml-1 rilopirox, the plasmalemma exhibited elongated invaginations, the number and size of the lipid droplets had increased and greatly enlarged mitochondria containing electron-dense deposits became visible. The vacuolar system was strongly expanded and occupied nearly the whole cell. Exposure to higher concentrations of the antifungal agent and prolonged incubation times resulted in complete cytoplasmic autolysis and membrane breakdown, while the fungal cell wall remained unaffected. After treatment with 0.5% rilopirox suspension gel on agar cultures, the extent of cellular damage was clearly enhanced and included all cell types of a treated yeast colony, i.e. single blastospores and pseudohyphae.

UI MeSH Term Description Entries
D008854 Microscopy, Electron Microscopy using an electron beam, instead of light, to visualize the sample, thereby allowing much greater magnification. The interactions of ELECTRONS with specimens are used to provide information about the fine structure of that specimen. In TRANSMISSION ELECTRON MICROSCOPY the reactions of the electrons that are transmitted through the specimen are imaged. In SCANNING ELECTRON MICROSCOPY an electron beam falls at a non-normal angle on the specimen and the image is derived from the reactions occurring above the plane of the specimen. Electron Microscopy
D011728 Pyridones Pyridine derivatives with one or more keto groups on the ring. Pyridinones
D002176 Candida albicans A unicellular budding fungus which is the principal pathogenic species causing CANDIDIASIS (moniliasis). Candida albicans var. stellatoidea,Candida stellatoidea,Dematium albicans,Monilia albicans,Myceloblastanon albicans,Mycotorula albicans,Parasaccharomyces albicans,Procandida albicans,Procandida stellatoidea,Saccharomyces albicans,Syringospora albicans
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics

Related Publications

H K Reitze, and D R Dannhorn, and H Hänel, and K A Seitz
April 1990, Mycoses,
H K Reitze, and D R Dannhorn, and H Hänel, and K A Seitz
September 1976, Mykosen,
H K Reitze, and D R Dannhorn, and H Hänel, and K A Seitz
February 1997, The Japanese journal of antibiotics,
H K Reitze, and D R Dannhorn, and H Hänel, and K A Seitz
November 1974, Sabouraudia,
H K Reitze, and D R Dannhorn, and H Hänel, and K A Seitz
January 1996, Mycoses,
H K Reitze, and D R Dannhorn, and H Hänel, and K A Seitz
June 1978, Sabouraudia,
H K Reitze, and D R Dannhorn, and H Hänel, and K A Seitz
July 2004, Oral diseases,
H K Reitze, and D R Dannhorn, and H Hänel, and K A Seitz
November 1972, Sabouraudia,
H K Reitze, and D R Dannhorn, and H Hänel, and K A Seitz
May 1975, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!